로딩 중…
StockDiggingStockDigging

Synergy Innovation Co., Ltd.

048870· KOSDAQ
₩1,760-2.44%
2026-06-19

Price Chart

Synergy Innovation Co., Ltd.-38.35%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap155.07B KRW
Revenue112.84B KRW
Net Income14.28B KRW
Total Assets335.01B KRW
Net Assets274.87B KRW
Employees69
Value
P/E10.86x
P/B0.56x
PEG0.09x
P/S1.37x
EV/EBITDA7.32x
FCF Yield6.07%
Profitability
ROE5.19%
ROA4.26%
Op. Margin16.13%
Revenue Growth-0.77%
Earnings Growth121.19%
Financial Health
Debt Ratio21.88%
Total Debt24.03B KRW
FCF9.41B KRW
Cash45.85B KRW
Current Ratio3.91x
Net Debt/EBITDA-1.20x
Dividend
Div. Yield1.95%
Div. Growth25.73%
Performance
1Y Return-38.35%
1M Return-1.35%
From 52W High-43.23%
1Y MDD-51.98%
Trading
Volume407,209 shares
Foreign Own.12.73%
Per Share
EPS69 KRW
BPS2,429 KRW

Company Info

CEO 박진형
Employees 69
Founded 1998
HQ 경기도 성남시, KR

Synergy Innovation, established in 1998 and listed on KOSDAQ in 2004, is a specialized microorganism culture media manufacturing company with five subsidiaries. It operates biotechnology, medical, and health functional food businesses, including investing in new drug development for brain and central nervous system diseases through Neurobiogen. The company produces in-vitro diagnostic and environmental monitoring products in ISO13485 and KGMP-certified environments, focusing on manufacturing facility expansion and production automation from 2024, from its headquarters in Seongnam-si, Gyeonggi-do.